JOURNAL OF PHARMACOLOGY AND
BIOMEDICINE
ISSN.2456-8244
Niosomes are the non-ionic surfactant-based vesicular system which may enhance anti-acne efficacy by improving bioavailability and intra-follicular penetration of the tazarotene. In the present study, we prepared tazarotene-loaded niosomes which were further incorporated in the carbopol 934 gel to alter the contact time to gain maximum benefits of the treatment. Prepared formulations of Niosome were optimized on basis of vesicle size, shape, surface charge and entrapment efficiency. % Entrapment efficiency and vesicle size of optimized Niosomes formulation (F-9) was found 78.85±0.25% and 212.4±0.32 nm respectively. Gel of F9 was formulated using carbopol 934 as the base. The in vitro anti acne activity of the niosomal gel was evaluated against Propionibacterium acnes using well diffusion method using clindamycin as the standard drug. The niosomal Gel NG-2 showed greater capacity (18.5±0.86, 19.0±0.7, 24.0±0.9) to inhibit bacterial growth than corresponding to plain gel (10.0±0.5, 12.0±0.8, 14.0±0.7) at the concentration level of 10µg/ml, 20µg/ml and 30µg/ml respectively.
NAMES:
ONLINE ISSN:2456-8244
Keywords: Tazarotene, noisome, gel, acne, stability, thin film hydration
DOI:
1. Teixeira V, Vieira R, Figueiredo A. Impacto psicossocial da acne. Rev da Soc Port Dermatol Venereol. 2012; 70(3): 291–296.
2. Nast A, Dréno B, Bettoli V, et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol. 2012; 26 (S1): 1–29.
3. Shah VP, Maibach HI, Topical Drug Bioavailability, Bioequivalence, and Penetration, 1, Springer, USA, 1993, 369-391.
4. Makeshwar K, Wasankar S. Niosomes: a novel drug delivery system. Asian J. Pharm. Res. 2013; 3: 16-20.
5. Goyal G, Garg T, Malik B, Chauhan G, Rath G, Goyal AK. Development and characterization of niosomal gel for topical delivery of benzoyl peroxide, Drug Delivery, 2015; 22(8): 1027–1042.
6. Balakrishnan P, Shanmugam S, Lee WS et al. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. International Journal of Pharmaceutics. 2009; 377 (1-2), 1–8.
7. Firthouse PUM, Halith SM, Wahab SU, Sirajudeen M, Mohideen SK. Formulation and evaluation of miconazole niosomes. International Journal of PharmTech Research. 2011; 3 (2): 1019–1022.
8. Sathali AAH, Sangeetha T. Formulation and evaluation of ocular niosomal in situ gel of levo?oxacin hemihydrates. Journal of Pharmacy Research. 2011; 4: 4331–4337.
9. Sathali AAH, Rajalakshmi G. Evaluation of transdermal targeted niosomal drug delivery of terbinafne hydrochloride. International Journal of PharmTech Research. 2010; 2 (3): 2081–2089.
10. Solanki AB, Parikh JR, Parikh RH, Patel MR. Evaluation of di erent compositions of niosomes to optimize aceclofenac transdermal delivery. Asian Journal of Pharmaceutical Sciences. 2010; 5 (3): 87–95.
11. Salih OS, Samein LH, Ali WK. Formulation and in vitro evaluation of rosuvastatin calcium niosomes. International Journal of Pharmacy and Pharmaceutical Sciences. 2013; 5 (4): 525–535.
12. Shinde UA, Kanojiya SS. Serratiopeptidase niosomal gel with potential in topical delivery. Journal of Pharmaceutics. 2014, Article ID 382959.
13. Nakatsuji T, Kao MC, Fang JY, et al. (2009). Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol 129: 2480–2488.